The latest move suggests Japan-based M3’s venture into India’s case-based, problem-solving community platform and medical test preparation business
M3, Inc., an online healthcare services provider based in Japan, has made it to the headlines for acquiring a majority share in NHPL (Neuroglia Health Private Limited), a mobile & web-based applications provider for medical professionals based in Bengaluru, India, for an unrevealed sum.
Reportedly, Neuroglia Health is the owner and operator of the mobile application named DailyRounds that helps doctors with case-based problem-solving. The company also operates Marrow, which is a platform for test preparation offering post-graduate specialty courses for medical schools in India.
The latest move marks the foray of Japan-based M3 into India’s medical test preparation business and case-based, problem-solving community platform.
For the record, M3 India, which owns HIPL (Health Impetus Private Limited), presently runs an online portal keeping doctors updated with the latest research material, evidence-based medicine, expert articles, practice guidelines, as well as medical news.
According to Amit Singh, Chief Executive, HIPL, M3 India, with this partnership, will now have access to as many as 450,000 doctors in India on a consolidated basis. The move is further anticipated to help M3 India in escalating its marketing support & market research businesses to pharmaceutical & medical devices, he added.
Dr. Deepu Sebin, the Chief Executive at Neuroglia Health, was reported stating that association with M3 will help Neuroglia with realizing its goal of being the largest doctor network in the nation, in terms of both the registered as well as active user base.
According to sources familiar with the knowledge of the matter, M3 also intends to import technologies & services developed in Japan and other international economies in India, including AI applications and job placement support services, in a bid to bring next-generation healthcare technologies onboard in the country.